Corvus Pharmaceuticals Inc (CRVS) is near the middle in its industry group according to InvestorsObserver. CRVS gets an overall rating of 38. That means it scores higher than 38 percent of stocks. Corvus Pharmaceuticals Inc gets a 36 rank in the Biotechnology industry. Biotechnology is number 29 out of 148 industries.
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Corvus Pharmaceuticals Inc Stock Today?
Corvus Pharmaceuticals Inc (CRVS) stock is trading at $3.63 as of 12:04 PM on Thursday, Feb 25, a decline of -$0.16, or -4.2% from the previous closing price of $3.79. The stock has traded between $3.61 and $3.79 so far today. Volume today is light. So far 549,427 shares have traded compared to average volume of 1,265,638 shares.